Search Results - "Numata, Shusuke"

Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry.

Authors: Ogasawara, Kazuyoshi Numata, Shusuke Hasegawa, Naomi et al.

Source: Neuropsychopharmacology Reports. Jun2022, Vol. 42 Issue 2, p221-225. 5p.

A Data‐Driven Psychiatric Disorder Subtype Defined by Significant Enlarged Ventricles and Cognitive Impairment: A Replication Study.

Authors: Onitsuka, Toshiaki Yasuda, Yuka Ito, Satsuki et al.

Source: Neuropsychopharmacology Reports. Mar2026, Vol. 46 Issue 1, p1-4. 4p.

Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.

Authors: Hasegawa, Naomi Yasuda, Yuka Yasui‐Furukori, Norio et al.

Source: Psychiatry & Clinical Neurosciences. Oct2023, Vol. 77 Issue 10, p559-568. 10p. 1 Diagram, 6 Charts, 2 Graphs.

Subjects: Mental health services, Psychiatrists, Mental depression, Hospital wards, Psychiatric treatment, Schizoaffective disorders

Geographic Terms: Japan

Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study

Authors: Takaesu, Yoshikazu Watanabe, Koichiro Numata, Shusuke et al.

Source: Psychiatry & Clinical Neurosciences. Oct2019, Vol. 73 Issue 10, p642-648. 7p. 4 Charts, 1 Graph.

Subjects: Mental depression, Psychiatric treatment, Psychiatry education, Psychiatrists, Schizophrenia, Psychoeducation, Adjunctive behavior

Eight‐Year Progression of Clinical Practice Implementation Following Guideline Training in the EGUIDE Project.

Authors: Ide, Kenta Yamamuro, Kazuhiko Yamada, Hisashi et al.

Source: Neuropsychopharmacology Reports. Mar2026, Vol. 46 Issue 1, p1-7. 7p.

Clinical behavior toward outpatients with major depressive disorder based on guideline education for psychiatrists.

Authors: Yamagata, Hirotaka Ide, Kenta Ochi, Shinichiro et al.

Source: Psychiatry & Clinical Neurosciences Reports. Dec2025, Vol. 4 Issue 4, p1-8. 8p.

Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.

Authors: Numata, Shusuke Nakataki, Masahito Hasegawa, Naomi et al.

Source: Neuropsychopharmacology Reports. Jun2021, Vol. 41 Issue 2, p199-206. 8p.

Long‐Term Impact of EGUIDE Training on Facility‐Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder: A Multicenter Study.

Authors: Hasegawa, Naomi Muraoka, Hiroyuki Arai, Yusuke et al.

Source: Neuropsychopharmacology Reports. Dec2025, Vol. 45 Issue 4, p1-8. 8p.

Association between serum folate levels and schizophrenia based on sex.

Authors: Tomioka, Yukiko Kinoshita, Makoto Umehara, Hidehiro et al.

Source: Psychiatry & Clinical Neurosciences. Sep2020, Vol. 74 Issue 9, p466-471. 6p. 2 Charts, 3 Graphs.

Subjects: Vitamin B6, Folic acid, Analysis of covariance, Serum, Schizophrenia

Maintenance pharmacotherapy after electroconvulsive therapy in inpatients with major depressive disorder: 198 prescriptions in a real-world clinical setting.

Authors: Igarashi, Shun Tsuboi, Takashi Hasegawa, Naomi et al.

Source: BMC Psychiatry. 10/9/2025, Vol. 25 Issue 1, p1-10. 10p.

X chromosome aneuploidies and schizophrenia: association analysis and phenotypic characterization.

Authors: Kushima, Itaru Aleksic, Branko Kimura, Hiroki et al.

Source: Psychiatry & Clinical Neurosciences. Dec2022, Vol. 76 Issue 12, p667-673. 7p. 2 Charts.

Subjects: X chromosome, Comparative genomic hybridization, Schizophrenia, Phenotypes, Mood stabilizers, Neuroleptic malignant syndrome

Left DLPFC activity is associated with plasma kynurenine levels and can predict treatment response to escitalopram in major depressive disorder.

Authors: Kamishikiryo, Toshiharu Okada, Go Itai, Eri et al.

Source: Psychiatry & Clinical Neurosciences. Aug2022, Vol. 76 Issue 8, p367-376. 10p. 1 Color Photograph, 1 Diagram, 1 Chart, 3 Graphs.

Subjects: Mental depression, Hamilton Depression Inventory, Kynurenine, Escitalopram

Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case–control study.

Authors: Lo, Tzuyao Kushima, Itaru Kimura, Hiroki et al.

Source: Neuropsychopharmacology Reports. Mar2024, Vol. 44 Issue 1, p42-50. 9p.

Beyond Binary Responsibility: A Framework for Biological Justice in the Epigenetic Era.

Authors: Mishra, Pragya Berryessa, Colleen M. Hagenbeek, Fiona A.

Source: Social Sciences (2076-0760). Jun2026, Vol. 15 Issue 6, p399. 28p.

The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project

Authors: Kyou, Yoshitaka Yasui-Furukori, Norio Hasegawa, Naomi et al.

Source: Annals of General Psychiatry. 12/26/2022, Vol. 21 Issue 1, p1-8. 8p.

Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project.

Authors: Hashimoto, Naoki Yasui-Furukori, Norio Hasegawa, Naomi et al.

Source: BMC Psychiatry. 6/28/2023, Vol. 23 Issue 1, p1-9. 9p. 1 Diagram, 2 Charts, 1 Graph.

Satisfaction with web‐based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project.

Authors: Iida, Hitoshi Okada, Tsuyoshi Nemoto, Kiyotaka et al.

Source: Neuropsychopharmacology Reports. Mar2023, Vol. 43 Issue 1, p23-32. 10p.

Interaction-Driven Dynamic Fusion for Multimodal Depression Detection: A Controlled Analysis of Gating and Cross-Attention Under Class Imbalance.

Authors: Matsumoto, Kazuyuki Kiuchi, Keita Umehara, Hidehiro et al.

Source: Brain Sciences (2076-3425). Apr2026, Vol. 16 Issue 4, p366. 21p.

Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.

Authors: Yasui‐Furukori, Norio Muraoka, Hiroyuki Hasegawa, Naomi et al.

Source: Neuropsychopharmacology Reports. Mar2022, Vol. 42 Issue 1, p3-9. 7p.

The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study.

Authors: Nakamura, Toshinori Furihata, Ryuji Hasegawa, Naomi et al.

Source: BMC Psychiatry. 5/29/2024, Vol. 24 Issue 1, p1-10. 10p.